Click below to hear recorded Q&A audio for each question from our live webcast audience.
If an IGRA tests positive in someone who is immunocompromised, what are the next steps?
What next, if the QuantiFERON®-TB Gold/Plus was indeterminate in a 19-year-old with no risk factor? The screening for TB was necessary for adoption process. Should a T-SPOT®.TB test be ordered?
In foreign-born who have had BCG, do you recommend IGRAs across the board, or just for those who are immunocompromised?
What are the advantages of IGRA over TST when screening healthcare workers for latent TB?
Out of all of the examples of immunocompromised patients, should all of these types of immunocompromised patients be screened for TB, or only in certain situations?
Should someone who is PPD-positive be tested annually via QuantiFERON Gold or T-SPOT.TB test?
With regards to latent TB, specifically those with BCG vaccine, what are the repercussions? Or are there any?
You covered many examples of immunocompromised patients. Should all people identified with these risk factors be screened for TB, or just in certain situations?
T-SPOT is a registered trademark of Oxford Immunotec Ltd.
QuantiFERON is a registered trademark of the QIAGEN Group